CAD 0.94
(1.08%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 46.86 Million USD | 5.17% |
2022 | 44.56 Million USD | 358.94% |
2021 | 9.7 Million USD | 8.25% |
2020 | 8.96 Million USD | -46.66% |
2019 | 16.81 Million USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 4.03 Million USD | -39.73% |
2024 Q2 | 3.34 Million USD | -16.97% |
2023 FY | 46.86 Million USD | 5.17% |
2023 Q2 | 13.65 Million USD | -1.39% |
2023 Q4 | 6.69 Million USD | -24.15% |
2023 Q3 | 8.82 Million USD | -35.39% |
2023 Q1 | 13.85 Million USD | -13.81% |
2022 FY | 44.56 Million USD | 358.94% |
2022 Q4 | 16.07 Million USD | 82.12% |
2022 Q3 | 8.82 Million USD | -24.33% |
2022 Q2 | 11.66 Million USD | 45.76% |
2022 Q1 | 8 Million USD | 85.44% |
2021 Q4 | 4.31 Million USD | 114.61% |
2021 Q1 | 1.54 Million USD | -25.96% |
2021 Q3 | 2.01 Million USD | 9.53% |
2021 FY | 9.7 Million USD | 8.25% |
2021 Q2 | 1.83 Million USD | 18.54% |
2020 Q3 | 1.84 Million USD | -27.9% |
2020 Q2 | 2.55 Million USD | 3.06% |
2020 Q1 | 2.47 Million USD | -15.92% |
2020 FY | 8.96 Million USD | -46.66% |
2020 Q4 | 2.09 Million USD | 13.49% |
2019 Q3 | 4.11 Million USD | 0.0% |
2019 Q4 | 2.94 Million USD | -28.37% |
2019 FY | 16.81 Million USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 5499.00 CAD | -852131.951% |
CanadaBis Capital Inc. | 11.78 Million CAD | -297.704% |
Decibel Cannabis Company Inc. | 41.85 Million CAD | -11.957% |
Delivra Health Brands Inc. | 6.39 Million CAD | -632.368% |
Entourage Health Corp. | 3.7 Million CAD | -1163.971% |
Lifeist Wellness Inc. | 5.34 Million CAD | -776.904% |
Cannara Biotech Inc. | 27.23 Million CAD | -72.101% |
Medicure Inc. | 13.98 Million CAD | -235.008% |
PharmaCielo Ltd. | -1.36 Million CAD | 3523.653% |
Rubicon Organics Inc. | 13.14 Million CAD | -256.632% |
BioSyent Inc. | 25.14 Million CAD | -86.394% |
Voyageur Pharmaceuticals Ltd. | -2185.00 CAD | 2144916.247% |